bpc 157 ind fda BPC-157 Injectable Peptide for Healing & Recovery Bpc-157 | Synopsis Details

5 mg vial + 1 mL bacteriostatic water = 5 mg/mL 2 mg dose = 0.4 mL (40 units on a standard insulin syringe) 2.5 mg dose = 0.5 mL (50 units) 5 mg vial + 2 mL bacteriostatic water = 2.5 mg/mL 2 mg dose = 0.8 mL (80 units) 2.5 mg dose = 1 mL (100 units, full syringe) 10 mg vial + 2 mL bacteriostatic water = 5 mg/mL 2 mg dose = 0.4 mL (40 units) 2.5 mg dose = 0.5 mL (50 units) 5 mg dose = 1.0 mL (100 units) Most people stick with the 1 mL per 5 mg ratio because the numbers come out clean and easy to draw

We don't want people to feel ashamed if they're using these substances, because that just drives them further into not seeking support if things do start to go wrong. What's the solution

The correct intervention is peptide discontinuation or dose reduction, or switching to an anticoagulant without antiplatelet overlap (heparin instead of warfarin, for example)

Cognitive changes such as memory problems or confusion may also occur, sometimes even before anaemia develops